257 related articles for article (PubMed ID: 30699382)
1. Disease burden attributable to endocrine-disrupting chemicals exposure in China: A case study of phthalates.
Cao Y; Li L; Shen K; Liu J
Sci Total Environ; 2019 Apr; 662():615-621. PubMed ID: 30699382
[TBL] [Abstract][Full Text] [Related]
2. Obesity, diabetes, and associated costs of exposure to endocrine-disrupting chemicals in the European Union.
Legler J; Fletcher T; Govarts E; Porta M; Blumberg B; Heindel JJ; Trasande L
J Clin Endocrinol Metab; 2015 Apr; 100(4):1278-88. PubMed ID: 25742518
[TBL] [Abstract][Full Text] [Related]
3. Male reproductive disorders, diseases, and costs of exposure to endocrine-disrupting chemicals in the European Union.
Hauser R; Skakkebaek NE; Hass U; Toppari J; Juul A; Andersson AM; Kortenkamp A; Heindel JJ; Trasande L
J Clin Endocrinol Metab; 2015 Apr; 100(4):1267-77. PubMed ID: 25742517
[TBL] [Abstract][Full Text] [Related]
4. Female Reproductive Disorders, Diseases, and Costs of Exposure to Endocrine Disrupting Chemicals in the European Union.
Hunt PA; Sathyanarayana S; Fowler PA; Trasande L
J Clin Endocrinol Metab; 2016 Apr; 101(4):1562-70. PubMed ID: 27003299
[TBL] [Abstract][Full Text] [Related]
5. Estimating burden and disease costs of exposure to endocrine-disrupting chemicals in the European union.
Trasande L; Zoeller RT; Hass U; Kortenkamp A; Grandjean P; Myers JP; DiGangi J; Bellanger M; Hauser R; Legler J; Skakkebaek NE; Heindel JJ
J Clin Endocrinol Metab; 2015 Apr; 100(4):1245-55. PubMed ID: 25742516
[TBL] [Abstract][Full Text] [Related]
6. Exposure to endocrine-disrupting chemicals in the USA: a population-based disease burden and cost analysis.
Attina TM; Hauser R; Sathyanarayana S; Hunt PA; Bourguignon JP; Myers JP; DiGangi J; Zoeller RT; Trasande L
Lancet Diabetes Endocrinol; 2016 Dec; 4(12):996-1003. PubMed ID: 27765541
[TBL] [Abstract][Full Text] [Related]
7. Neurobehavioral deficits, diseases, and associated costs of exposure to endocrine-disrupting chemicals in the European Union.
Bellanger M; Demeneix B; Grandjean P; Zoeller RT; Trasande L
J Clin Endocrinol Metab; 2015 Apr; 100(4):1256-66. PubMed ID: 25742515
[TBL] [Abstract][Full Text] [Related]
8. Burden of disease and costs of exposure to endocrine disrupting chemicals in the European Union: an updated analysis.
Trasande L; Zoeller RT; Hass U; Kortenkamp A; Grandjean P; Myers JP; DiGangi J; Hunt PM; Rudel R; Sathyanarayana S; Bellanger M; Hauser R; Legler J; Skakkebaek NE; Heindel JJ
Andrology; 2016 Jul; 4(4):565-72. PubMed ID: 27003928
[TBL] [Abstract][Full Text] [Related]
9. [Potential sources of phthalates and bisphenol A and their significance in the development of metabolic diseases].
Mráz M; Svačina Š; Kotrlíková E; Piecha R; Vrbík K; Pavloušková J; Lacinová Z; Vavrouš A; Müllerová D; Matějková D; Křížová J
Cas Lek Cesk; 2016; 155(3):11-5. PubMed ID: 27256142
[TBL] [Abstract][Full Text] [Related]
10. Phthalates - widespread occurrence and the effect on male gametes. Part 2. The effects of phthalates on male gametes and on the offspring.
Dobrzyńska MM
Rocz Panstw Zakl Hig; 2016; 67(3):209-21. PubMed ID: 27546318
[TBL] [Abstract][Full Text] [Related]
11. The effects of phthalate and nonylphenol exposure on body size and secondary sexual characteristics during puberty.
Hou JW; Lin CL; Tsai YA; Chang CH; Liao KW; Yu CJ; Yang W; Lee MJ; Huang PC; Sun CW; Wang YH; Lin FR; Wu WC; Lee MC; Pan WH; Chen BH; Wu MT; Chen CC; Wang SL; Lee CC; Hsiung CA; Chen ML
Int J Hyg Environ Health; 2015 Oct; 218(7):603-15. PubMed ID: 26163779
[TBL] [Abstract][Full Text] [Related]
12. Exposure to Polybrominated Diphenyl Ethers and Phthalates in China: A Disease Burden and Cost Analysis.
Wang H; Zhang Y
Toxics; 2022 Dec; 10(12):. PubMed ID: 36548599
[TBL] [Abstract][Full Text] [Related]
13. Exposure to Endocrine Disrupting Chemicals in Canada: Population-Based Estimates of Disease Burden and Economic Costs.
Malits J; Naidu M; Trasande L
Toxics; 2022 Mar; 10(3):. PubMed ID: 35324771
[TBL] [Abstract][Full Text] [Related]
14. Human exposure to endocrine disrupting chemicals and fertility: A case-control study in male subfertility patients.
Den Hond E; Tournaye H; De Sutter P; Ombelet W; Baeyens W; Covaci A; Cox B; Nawrot TS; Van Larebeke N; D'Hooghe T
Environ Int; 2015 Nov; 84():154-60. PubMed ID: 26292060
[TBL] [Abstract][Full Text] [Related]
15. Endocrine Aspects of Environmental "Obesogen" Pollutants.
Nappi F; Barrea L; Di Somma C; Savanelli MC; Muscogiuri G; Orio F; Savastano S
Int J Environ Res Public Health; 2016 Jul; 13(8):. PubMed ID: 27483295
[TBL] [Abstract][Full Text] [Related]
16. Phthalate Exposure, Adolescent Health, and the Need for Primary Prevention.
Sears CG; Braun JM
Endocrinol Metab Clin North Am; 2020 Dec; 49(4):759-770. PubMed ID: 33153678
[TBL] [Abstract][Full Text] [Related]
17. An integrated exposure assessment of phthalates for the general population in China based on both exposure scenario and biomonitoring estimation approaches.
Cao Y; Liu J; Liu Y; Wang J; Hao X
Regul Toxicol Pharmacol; 2016 Feb; 74():34-41. PubMed ID: 26654930
[TBL] [Abstract][Full Text] [Related]
18. Calculation of the disease burden associated with environmental chemical exposures: application of toxicological information in health economic estimation.
Grandjean P; Bellanger M
Environ Health; 2017 Dec; 16(1):123. PubMed ID: 29202828
[TBL] [Abstract][Full Text] [Related]
19. A global assessment of phthalates burden and related links to health effects.
Katsikantami I; Sifakis S; Tzatzarakis MN; Vakonaki E; Kalantzi OI; Tsatsakis AM; Rizos AK
Environ Int; 2016 Dec; 97():212-236. PubMed ID: 27669632
[TBL] [Abstract][Full Text] [Related]
20. Disparities in Environmental Exposures to Endocrine-Disrupting Chemicals and Diabetes Risk in Vulnerable Populations.
Ruiz D; Becerra M; Jagai JS; Ard K; Sargis RM
Diabetes Care; 2018 Jan; 41(1):193-205. PubMed ID: 29142003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
